Health knowledge made personal
Posted
Sat 13 Sep 2008 4:31am
(April 17, 2006)--Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis... of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing
Read on »
Posted
Wed 21 Apr 2010 6:29am
risk.
Over the last several years, a breast cancer research clinical trial called Study of Tamoxifen and Raloxifene (STAR) has been running to compare the effectiveness of raloxifene to tamoxifen for reducing breast cancer risk. The updated results from this trial were presented on Monday at the 101st Annual Meeting of the American Association
Read on »
Posted
Wed 23 Sep 2009 10:16pm
Breast Cancer Prevention Drugs and Cognition Studied
Researchers say neither tamoxifen not raloxifene shows clear advantage in preserving cognition
23 sept 2009-- The selective estrogen receptor modulators tamoxifen and raloxifene, used for breast cancer prevention in postmenopausal women, have similar effects on cognition, according to a study
Read on »
Posted
Sat 13 Sep 2008 3:59pm
from NCI about a study looking at tamoxifen and raloxifene for breast cancer prevention. Many trumpeted the summary findings — “raloxifene is as effective, with fewer side....
Technorati Tags: breast cancer, tamoxifen, raloxifene, drugs, prevention, treatment, side effects, STAR
Read on »
Posted
Wed 01 Oct 2008 10:28pm
1 Comment
Good news for women: A large government sponsored study of nearly 20,000 postmenopausal women found that raloxifene (marketed under the name of Evista) reduces their chance... and blood clots.
Because an estimated 500,000 women use raloxifene to reduce the risk of osteoporosis, many will be more comfortable using it for breast cancer protection, several
Read on »
Posted
Sat 06 Jun 2009 10:37pm
Medications Reduce Postmenopausal Fracture Risk
Teriparatide, raloxifene linked to reduced risk of new adjacent and nonadjacent vertebral fracture
07 june 2009-- In postmenopausal women with osteoporosis, teriparatide and raloxifene may significantly reduce the risk of vertebral fractures, according to a study published in the June 1 issue
Read on »
Posted
Thu 19 Nov 2009 10:02pm
from NCI about a study looking at tamoxifen and raloxifene for breast cancer prevention. Many trumpeted the summary findings — “raloxifene is as effective, with fewer side....
Technorati Tags: breast cancer, tamoxifen, raloxifene, drugs, prevention, treatment, side effects, STAR
This entry was posted
on Tuesday, May 9th, 2006 at 10:18 am
Read on »
Posted
Wed 06 Oct 2010 2:47pm
The osteoporosis drug raloxifene may be useful in treating kidney disease in women, suggests a new study led by Michal Melamed, M.D., M.H.S., assistant professor... of clinical medicine and associate chair for undergraduate medical education at Einstein, looked at data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial, a study
Read on »
Posted
Wed 01 Oct 2008 8:19pm
A DRUG USED TO PREVENT AND treat osteoporosis in postmenopausal women was recently found to have a favorable effect on the heart.
According to Lotis Calinawan of the drug manufacturer Eli Lilly, a study found that women who have increased risk for cardiovascular events and who took the drug raloxifene (Evista) for four years had a 40 percent reduction
Read on »
